Immuneering Corporation
IMRX
$5.60
-$0.325-5.49%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.07% | 16.65% | -23.66% | -3.68% | 1.59% |
| Total Depreciation and Amortization | -0.86% | -0.86% | -3.01% | -1.53% | 0.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.32% | 1.13% | 4.09% | -2.60% | 23.40% |
| Change in Net Operating Assets | 464.08% | -153.35% | 357.27% | -190.77% | 126.99% |
| Cash from Operations | 32.91% | 2.96% | -7.71% | -16.88% | 25.60% |
| Capital Expenditure | 76.40% | 5.32% | -77.36% | 83.84% | 12.53% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 201.66% | -208.20% | -76.67% |
| Cash from Investing | 76.40% | -100.16% | 201.39% | -209.02% | -76.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.98% | 15,884.49% | -98.02% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.45% | 33,784.39% | -100.94% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3,308.67% | 96.92% | 37.61% | -121.43% | -195.31% |